Biotech firm Athira Pharma hit by class action lawsuits following image manipulation claims
Leen Kawas, CEO of Athira Pharma, went on leave earlier this month. (Athira Pharma photo) The lawsuits have started. Less than a week after the CEO of Athira Pharma was given a temporary leave of absence on allegations of altered images in the scientific papers she wrote, three class action lawsuits were filed on behalf … Read more